Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Base Pair Biotechnologies Inc (AKA: Ice Nine Biotechnologies)
Profile last edited on: 8/6/20      CAGE: 6S6K9      UEI: FFAKKLCKBNN7

Business Identifier: Aptamer based technologies and research services
Year Founded
2012
First Award
2013
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

8619 Broadway Street Suite 100
Pearland, TX 77584
   (832) 230-5518
   info@basepairbio.com
   www.basepairbio.com
Location: Single
Congr. District: 22
County: Brazoria

Public Profile

Base Pair Biotechnologies, Inc. is a spin-off of parent company, BioTex, Inc., the original developer of several molecular biology and diagnostic technologies currently being commercialized. Base Pair Biotechnologies, Inc. offers discovery of aptamer (DNA- and RNA-based) affinity ligands. Base Pair Bio's aptamer discovery is powered by a patent-pending, multiplexed approach to aptamer identification enabling development of custom aptamers at quicjly and at reasonable cost.

Extent of SBIR involvement

User Avatar
Phase I Awards
11
Phase II Awards
2
Conversion Rate
18.18%
Phase I Dollars
$2,954,233
Phase II Dollars
$1,842,383
Total Awarded
$4,796,616

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 2 NIH $1,457,689
Project Title: Neonatal Opioid Screening Using Aptamers and Compensated Interferometry
2020 1 NIH $221,014
Project Title: Rapid, Quantitative Point-Of-Care Measurement of Tuberculosis Treatment Adherence
2020 2 USDA $700,000
Project Title: Optimization of a Prototype Lateral Flow Test for Dicamba
2019 1 NIH $600,000
Project Title: Development of Aptamer Affinity Reagents to Immune Targets in Non-human Disease Models
2019 1 NIH $600,000
Project Title: Development of Aptamer Affinity Reagents to Immune Targets in Non-human Disease Models

Key People / Management

  Bill Jackson -- Founder and Chief Scientist

  Victoria L Singer -- President and Chief Executive Officer

  Rob Batchelor -- Director of Aptamer Development

  George W Jackson

  Mark Morris -- Senior Scientist

  Christopher Quan Esq -- General Counsel

  Lisa Thurston -- Business Development/Marketing

  Amy Willson -- Senior Manager, Marketing

Company News

There are no news available.